Why the study?
Does atrial natriuretic peptide reduce COX-2 expression and PGE(2) production in lipopolysaccharide-activated murine macrophages?
Population
Murine macrophages and mice induced by lipopolysaccharide
Comparison
Atrial natriuretic peptide, C-type natriuretic… vs Control (LPS alone)
Design
Preclinical
Authors
Loading...
May inform anti-inflammatory research; leaves open human translation of NPR-C-mediated COX-2 effects.
Does atrial natriuretic peptide reduce COX-2 expression and PGE(2) production in lipopolysaccharide-activated murine macrophages?
ANP attenuates COX-2 expression and PGE(2) production in LPS-activated macrophages via the NPR-C receptor, highlighting its immunomodulatory potential.
Kiemer et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: